Lead Product(s) : L-Fucose
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The active pharmaceutical ingredient (API) in AVTX-803 is L-fucose an oral formulation of L-fucose that enhances fucosylation of proteins in the absence of a functioning GDP-fucose transporter, partially restoring protein function.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
August 02, 2022
Lead Product(s) : L-Fucose
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Fucose
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : L-Fucose is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Leukocyte-Adhesion Deficiency Syndrome.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
July 18, 2022
Lead Product(s) : L-Fucose
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Fucose
Therapeutic Area : Genetic Disease
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
Details : L-Fucose is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Congenital disorder of glycosylation, type 2C.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
November 28, 2017
Lead Product(s) : L-Fucose
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable